Half-Life Cancer Research Results
Half-Life, Half-Life: Click to Expand ⟱
| Source: |
| Type: |
For many drugs, the half-life is the time it takes for half of the drug’s active substance to be eliminated from the bloodstream.
In medicine, knowing a drug’s half-life helps in designing treatment regimens that reduce adverse effects.
|
Lung, Lung Cancer: Click to Expand ⟱
Lung CSC (Cancer Stem Cells) markers (CD133, CD44, ALDHA1, Nanog and Oct4)
|
Scientific Papers found: Click to Expand⟱
ACLY↓, BioAv↓, Dose↝, TumCP↓, FASN↓, IDH1↓, Apoptosis↑, ROS↑, Half-Life↝,
OCR↑, OXPHOS↑, Half-Life↝, AntiTum↑,
selectivity↑, AMPK↑, Risk↓, Half-Life↝, ChemoSen↑,
Showing Research Papers: 1 to 3 of 3
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 3
Pathway results for Effect on Cancer / Diseased Cells:
Redox & Oxidative Stress(tgid=1) ⓘ
OXPHOS↑, 1, ROS↑, 1,
Mitochondria & Bioenergetics(tgid=3) ⓘ
OCR↑, 1,
Core Metabolism/Glycolysis(tgid=4) ⓘ
ACLY↓, 1, AMPK↑, 1, FASN↓, 1, IDH1↓, 1,
Cell Death(tgid=5) ⓘ
Apoptosis↑, 1,
Migration(tgid=13) ⓘ
TumCP↓, 1,
Drug Metabolism & Resistance(tgid=21) ⓘ
BioAv↓, 1, ChemoSen↑, 1, Dose↝, 1, Half-Life↝, 3, selectivity↑, 1,
Functional Outcomes(tgid=23) ⓘ
AntiTum↑, 1, Risk↓, 1,
Total Targets: 16
Pathway results for Effect on Normal Cells:
Total Targets: 0
Scientific Paper Hit Count for: Half-Life, Half-Life
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:15 Cells:% prod#:% Target#:1109 State#:% Dir#:4
wNotes=0 sortOrder:rid,rpid
Home Page